Acta Neuropathol
- TIWARI A, Pawlowski KD, Balyasnikova IV
Improving T-cell engager efficacy in glioblastoma with multi-antigen targeting
and novel delivery approaches.
Acta Neuropathol. 2026;152:15.
AJNR Am J Neuroradiol
- REECHER HM, Duenweg SR, Lowman AK, Winiarz A, et al
A Comparison of Radio-Pathomic, Diffusion, and Perfusion Imaging Features for
Identifying Pseudoprogression in Glioblastoma.
AJNR Am J Neuroradiol. 2026 Aug 7:ajnr.A9574. doi: 10.3174/ajnr.A9574.
- MARK IT, Nickel D, Kollasch P, Dueker K, et al
Contrast-Enhanced T2-Weighted STIR Imaging of Pituitary Adenomas.
AJNR Am J Neuroradiol. 2026;47:2160-2162.
- DAGHER R, Sun P, Al Qudah H, Kaya D, et al
Dynamic Susceptibility Contrast MRI Using Gadopiclenol for Evaluation of Relative
Cerebral Blood Volume at 3T: A Comparison with Gadobutrol.
AJNR Am J Neuroradiol. 2026;47:2181-2186.
BMC Neurol
- SECEN AE, Guresci S, Ozbakir MO, Gunduz UK, et al
Clinical presentation and survival outcome of solitary fibrous tumors of the
central nervous system: a single center study.
BMC Neurol. 2026;26:499.
Childs Nerv Syst
- MORITA K, Nakashima Y, Kurose N, Kawashima A, et al
Intraoperative diagnosis of myxoid glioneuronal tumor guiding safe limited
resection: a case report.
Childs Nerv Syst. 2026;42:319.
- ABDALLAH AM, Hulliel AF, Saleh D, Mukahal M, et al
Successful pre-operative endovascular intraventricular meningioma embolization: a
systematic review and pediatric case analysis.
Childs Nerv Syst. 2026;42:320.
- VIRGIN KL, Fletcher M, Ayub J, Harmsen H, et al
Time to adjuvant treatment for newly diagnosed pediatric brain tumors in the
molecular era: a single center retrospective study.
Childs Nerv Syst. 2026;42:322.
- KAHRAMAN S, Cal MA
Unilateral hemilaminectomy for pediatric intradural spinal tumors: a consecutive
case series.
Childs Nerv Syst. 2026;42:321.
- DIXIT S, Kumar A, Datta A, Tripathi D, et al
Postoperative meningitis in pediatric posterior fossa tumors: risk stratification
and the role of early CSF cytology.
Childs Nerv Syst. 2026;42:324.
- LI L, Zhang J, Wu W
Second primary malignancies among childhood medulloblastoma survivors: a
population-based competing risk analysis.
Childs Nerv Syst. 2026;42:326.
Clin Cancer Res
- KIM K, Song SW, Jeon Y, Choi S, et al
Phase I trial of IL13Ralpha2-targeted CAR-T cell therapy for recurrent malignant
glioma: clinical results and pharmacokinetics.
Clin Cancer Res. 2026 Aug 4. doi: 10.1158/1078-0432.CCR-26-0645.
J Neurooncol
- NIRANJAN A, Reyes JS, Hadjipanayis CG, Bernstein K, et al
Stereotactic radiosurgery offers long-term tumor control for craniopharyngioma: a
multi-institutional analysis of clinical and imaging outcomes from the
International Radiosurgery Research Foundation (IRRF).
J Neurooncol. 2026;179:24.
- JU K, Park JE, Mahmud SZ, Blair L, et al
Multi-molecular saturation-transfer MR fingerprinting for differentiating tumor
progression from treatment-related change in post-treatment IDH-wildtype
glioblastoma: a feasibility study.
J Neurooncol. 2026;179:25.
- BEGAGIC E, Beculic H, Harcinovic AK, Huseinspahic N, et al
Brain metastases in triple-negative breast cancer: a systematic review of current
trends, treatment strategies, and outcomes.
J Neurooncol. 2026;179:27.
- BAKOS J, Stangl F, Behrens L, Berlis A, et al
The risk of sinus vein thrombosis in patients treated with intraoperative
radiotherapy for sinus adjacent tumours.
J Neurooncol. 2026;179:26.
- DESAI A, Malik M, Cook CJ, Fei-Zhang DJ, et al
Individual and community-level associations of social determinants with pituitary
adenoma disparities in the US.
J Neurooncol. 2026;179:29.
- TRKOVA K, Vicha A, Sumerauer D, Ghasemi DR, et al
Pediatric ependymoma in the molecular era: real-world experience with diagnostic
correlation and long-term clinical outcomes.
J Neurooncol. 2026;179:30.
- SCHMIDT L, Santaniello SD, Krenzlin H, Kronfeld A, et al
DTI-ALPS is not independently associated with overall survival beyond established
prognostic factors in glioblastoma.
J Neurooncol. 2026;179:33.
- MAKHLOUF N, Zehani A, Kallel J, Chelly I, et al
CD34 and p16 expression in central nervous system solitary fibrous tumors: an
exploratory clinicopathologic study.
J Neurooncol. 2026;179:32.
- SYED SA, Coppin FM, Latzman S, Teng CL, et al
Longitudinal connectomics-based tractometry for characterizing white matter
reorganization following brain tumor surgery: a proof-of-concept case series.
J Neurooncol. 2026;179:28.
- PATEL CB, Robinson TJ, Kurz SC, Ginat DT, et al
Distinguishing true progression from treatment effects in glioblastoma: a
practical, evidence-graded imaging framework for the multidisciplinary team.
J Neurooncol. 2026;179:34.
- HOUNCHONOU HF, Polemikos M, Pirayesh A, Bajgora G, et al
Molecularly diagnosed glioblastoma: clinical presentation and outcomes.
J Neurooncol. 2026;179:35.
- KRIGERS A, Demetz M, Bergmeister L, Moser P, et al
Actin, connexin-43 and GAP-43 expression in gliomas: real-world associations with
IDH status, tumor burden and survival.
J Neurooncol. 2026;179:36.
J Neurosurg
- LU W, Liu Y, Wu X, Ma L, et al
Metabolic boundary resection of glioblastoma correlates with clinical outcome and
survival analysis: a comparative cohort study.
J Neurosurg. 2026 Aug 7:1-10. doi: 10.3171/2026.3.JNS252582.
Nat Rev Neurol
- KIANI L
Tumour and microenvironment targeting of glioblastoma with dual-acting CAR T
cells.
Nat Rev Neurol. 2026 Aug 5. doi: 10.1038/s41582-026-01254.
Neuro Oncol
- ELGUINDY M, Raleigh DR
Focused ultrasound to track circulating extracellular vesicles in glioblastoma.
Neuro Oncol. 2026 Aug 6:noag184. doi: 10.1093.
- LIU M, Wang H, Guo J, Li X, et al
Multi-transcriptomics analysis identifies NNAT as a key molecule driving the
invasive phenotype across all lineages of pituitary adenomas.
Neuro Oncol. 2026;28:1953-1969.
- ZARAGORI T, Rozenblum L, Rovera G, Stien G, et al
Automatic extraction of PET RANO criteria with an externally validated deep
learning model: Application to [18F]FDOPA PET imaging.
Neuro Oncol. 2026;28:2053-2064.
- CHO M, Kim M, Kim H, Choi K, et al
A comprehensive clinical, molecular, radiological, and surgical analysis for
predicting prognosis in isocitrate dehydrogenase-mutant astrocytoma patients.
Neuro Oncol. 2026;28:2016-2029.
- ZHAO L, Clark PA, Shireman JM, Schepp CL, et al
Radiopharmaceutical therapy provides superior survival advantage for
leptomeningeal metastasis compared to external beam radiotherapy.
Neuro Oncol. 2026;28:1986-1998.
- VIRATA MC, Samanamud J, Slocum CC, Kandoi S, et al
Expanding the molecular grading criteria in IDH-mutant astrocytoma.
Neuro Oncol. 2026;28:1921-1932.
PLoS One
- GONG B, Liu S, Chen S, Yu L, et al
Association between preoperative chronic steroid use and pulmonary embolism in
adult tumor craniotomy: Linking role of platelet-to-white blood cell ratio.
PLoS One. 2026;21:e0355416.
Proc Natl Acad Sci U S A
-
Retraction for Khan et al., Macrophage TBK1 signaling drives the development and
outgrowth of breast cancer brain metastasis.
Proc Natl Acad Sci U S A. 2026;123:e2625886123.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016